首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1575767

蝴蝶針套裝市場 - 2024-2031

Butterfly Needle Sets Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年，全球蝴蝶針套裝市場達到2.2048億美元，預計到2031年將達到3.7904億美元，2024-2031年預測期間複合年成長率為7.1%。

蝴蝶針，也稱為頭皮靜脈裝置或翼式輸液器，是一種用於從靜脈抽取血液或透過靜脈注射藥物的工具。它由一根窄針、兩個軟性翼、一根透明軟性管和一個連接器組成。

它廣泛用於透過採集血液樣本並提供快速小量輸液來治療攣縮患者和小兒。它主要用於靜脈穿刺（也稱為翼式輸液器或蝴蝶裝置）。

市場動態：

驅動程式和限制

慢性病盛行率增加

蝴蝶針被認為比普通針更精確且疼痛更少。隨著越來越多的慢性病患者需要長期護理，醫療保健提供者更有可能使用設備來提高患者的舒適度並最大程度地減少擔憂。人口老化更容易患慢性病，導致對蝴蝶針套件等醫療設備的需求增加，因為老年人經常需要定期進行醫療檢查。

例如，根據美國疾病管制與預防中心2022年的報告，估計美國每10個成年人中約有6人患有慢性病，其中每10個成年人中就有4人患有兩種以上慢性病。這增加了治療期間所需程序對蝶形針組的需求。因此，上述因素預計將推動市場成長。

蝴蝶針成本高

與標準注射器和針頭相比，蝶形針頭通常更昂貴，特別是當涉及安全針頭或預充式注射器等複雜功能時。這對於擔心成本的消費者和醫療保健專業人士來說可能是一種威懾，尤其是在資源匱乏的地區。因此，它可能會阻礙市場的成長。

細分市場分析

全球蝶形針組市場根據量規類型、應用、最終用戶和地區進行細分。

25G蝶形針領域預計將佔據市場佔有率

25G蝶形針由於其相對於其他類型的優勢和應用，預計將在市場佔有率中佔據主導地位。與較小規格的針頭（例如22G、21G）相比，25G 針頭的直徑較小，這使得它們更細，並且在插入過程中可能會引起較少的不適，特別是對於年輕人或靜脈脆弱的患者。

由於它們的尺寸很小，它們在穿刺部位造成的組織損傷較少，從而促進更快的癒合，並可能減輕腫脹或瘀傷。靜脈細弱的患者最好使用 25G 針頭，因為較大的針頭可能難以放置，甚至可能導致靜脈塌陷。對於某些需要較慢血流管理的抽血或注射等操作，可能需要較小的尺寸。

由於尺寸減小，控制和精確度提高，手術過程中意外靜脈損傷的可能性較小。因此，上述因素正在增加對25G蝶形針的需求，並預計將在預測期內保持該細分市場的主導地位。

市場地域佔有率

北美預計將在蝴蝶針套市場佔有率中佔據重要地位

預計北美將在市場成長中佔據主導地位。該地區有多家醫院、診所和其他醫療機構，配備了最先進的工具和技術。由於這種強大的基礎設施，市場正在不斷成長，這導致基於蝴蝶針的醫療手術和治療的使用增加。

癌症和糖尿病等慢性疾病在北美非常常見，這使得蝶形針在手術中的使用越來越普遍。例如，根據美國癌症協會估計，2024年美國將有約200萬癌症病例。因此，上述因素預計將保持該地區在市場佔有率上的主導地位。

Butterfly needles are considered to be more precise and less painful than regular needles. As more patients with chronic diseases require long-term care, healthcare providers are more likely to use devices to improve patient comfort and minimize concern. The aging population is more vulnerable to chronic diseases, resulting in increased demand for medical devices such as butterfly needle sets, as elderly people often need regular medical tests.

For instance, according to the report by the Centers for Disease Control and Prevention in 2022, it is estimated that around 6 in 10 adults in the US are suffering from chronic diseases and among them 4 in 10 adults suffer from more than two chronic diseases at a time. This increases the need for butterfly needle sets for the procedures required during the treatment. Thus, the above factors are expected to drive the market growth.

High cost of the butterfly needles

Compared to standard syringes and needles, butterfly needles are often more costly, particularly when it comes to sophisticated features like safety needles or pre-filled syringes. This can be a deterrent for consumers and healthcare professionals who are concerned about costs, especially in areas with little resources. Thus, it can hinder the market growth.

Market Segment Analysis

The global butterfly needle sets market is segmented based on the gauge type, applications, end-users and region.

The 25G butterfly needles segment is expected to dominate the market share

25G butterfly needles are expected to hold the dominant position in the market share due to their advantages and applications over the other types. Compared to lesser gauge needles (e.g., 22G, 21G), 25G needles have a smaller diameter, which makes them thinner and may cause less discomfort during insertion, particularly for youngsters or patients with delicate veins.

Due to their tiny size, they cause less tissue damage at the puncture site, which promotes quicker healing and may lessen swelling or bruises. Patients with thin or frail veins are best served by 25G needles since bigger needles may be difficult to place or may even induce vein collapse. For operations like certain blood draws or injections that need slower blood flow management, a smaller size could be desirable.

Because of the reduced size, there is less chance of unintentional vein injury during operations due to improved control and precision. Thus, the above factors are increasing the demand for 25G butterfly needles and are expected to hold the segment in the dominant position in the forecast period.

Market Geographical Share

North America is expected to hold a significant position in the butterfly needle sets market share

North America is expected to hold a dominant position in the market growth. There are several hospitals, clinics, and other medical institutions in the region that are furnished with cutting-edge tools and technology. The market is growing because of this strong infrastructure, which leads to an increase in the use of butterfly needle-based medical operations and treatments.

Chronic diseases like cancer and diabetes are very common in North America, which makes the use of butterfly needles in procedures increasingly common. For instance, according to the American Cancer Society, it is estimated that there will be around 2 million cancer cases in the US in 2024. It is estimated that around 5,500 cancer cases will be diagnosed each day. Thus, the above factors are expected to hold the region in the dominant position in the market share.

Market Segmentation

By Gauge Type

21G Butterfly Needles

23G Butterfly Needles

25G Butterfly Needles

Others

By Applications

Delivery of Medications

IV Rehydration

Blood Transfusion

Others

By End-users

Hospitals

Blood Banks

Pathology Labs

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the market include Nipro Corporation, Medline Industries, Terumo Corporation, Cardinal Health, Becton, Dickinson and Company, Kawasumi Laboratories America, ZIBO ECONST MEDICAL INSTRUMENT CO., LTD., Al Shifa Medical Products Co, Vitaimed Instrument Co., Ltd., McKesson Medical-Surgical Inc. among others.

Why Purchase the Report?

To visualize the global butterfly needle sets market segmentation based on the gauge type, applications, end-users, and region as well as understand key commercial assets and players.

identify commercial opportunities by analyzing trends and co-development.

excel data sheet with numerous data points of the butterfly needle sets market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global butterfly needle sets market report would provide approximately 55 tables, 58 figures and 180 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Gauge Type
3.2. Snippet by Applications
3.3. Snippet by End-users
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increase in the prevalence of chronic diseases
- 4.1.2. Restraints
  - 4.1.2.1. High cost of the butterfly needles
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Gauge Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 6.1.2. Market Attractiveness Index, By Gauge Type
6.2. 21G Butterfly Needles*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. 23G Butterfly Needles
6.4. 25G Butterfly Needles
6.5. Others

7. By Applications

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 7.1.2. Market Attractiveness Index, By Applications
7.2. Delivery of Medications*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. IV Rehydration
7.4. Blood Transfusion
7.5. Others

8. By End-users

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 8.1.2. Market Attractiveness Index, By End-users
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Blood Banks
8.4. Pathology Labs
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. Australia
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Nipro Corporation*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Medline Industries
11.3. Terumo Corporation
11.4. Cardinal Health
11.5. Becton, Dickinson and Company
11.6. Kawasumi Laboratories America
11.7. ZIBO ECONST MEDICAL INSTRUMENT CO., LTD.
11.8. Al Shifa Medical Products Co
11.9. Vitaimed Instrument Co., Ltd.
11.10. McKesson Medical-Surgical Inc. (*LIST NOT EXHAUSTIVE)